Welcome to the BCI podcast! In this episode, we have the honor of hosting Dr. Russ Teichert, a visionary scientist and entrepreneur in the field of drug discovery. Dr. Teichert is the CEO and founder of Scintillant Bioscience, a pioneering company focused on developing innovative cell-based imaging assays for drug discovery. With over a decade of experience as a research faculty member at the University of Utah and previous work at Vertex Pharmaceuticals, Dr. Teichert brings a wealth of knowledge and expertise to our conversation. His remarkable journey and groundbreaking research have positioned him as a leading figure in the biotech industry. Join us as we delve into Dr. Teichert's inspiring story, exploring his passion for advancing drug discovery through cutting-edge technologies. We'll discuss the transformative potential of cell-based imaging assays and gain insights into the future of the field. Prepare to be inspired and captivated by Dr. Teichert's expertise and vision. Tune in to gain valuable knowledge and stay ahead of the latest developments in the exciting world of drug discovery. #BCIpodcast #DrugDiscovery #BiotechIndustry #CellBasedImaging #Innovation #Research #Entrepreneurship #Scientist #PhD #MBA #BiotechStartup #FutureOfMedicine #ScienceAndTechnology #LifeScience #BCIcommunity #Inspiration #ExpertInsights #PodcastEpisode

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related